SARCULATOR vs D798EC00001
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
SARCULATOR
This medical tool provides physicians with predictive models for retroperitoneal and extremity sarcoma patients. It estimates overall survival and disease-free survival, serving as an informative resource to enhance physician predictive capabilities.
- Predictive models for sarcoma patients
- Estimates 5-year overall survival
- Estimates 5-year disease-free survival
- Estimates 10-year overall survival
- Estimates cumulative incidence of distant metastasis
- Informative tool for physicians
Read full descriptionHide full description
This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician. Two kinds of predictions are possible: - RPS: 5-year overall survival (OS) and 5-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. . - ESTS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients.
D798EC00001
Read full descriptionHide full description
MedImmune D798EC00001 eCOA App is intended for use to collect patient reported outcomes relating to a clinical trial. Patients must be given accounts by a participating site in order to log in to the app. Patients can report daily symptom changes, and report changes to health associated with the study
Screenshots
Verdict
The clearest difference is update cadence: D798EC00001 at every 5 weeks against SARCULATOR's every 6 months. D798EC00001 also leads on iOS requirement (12.0 vs 15.0). On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
SARCULATOR ships an update every 6 months, D798EC00001 every 5 weeks. The most recent releases landed on October 24, 2026 and October 30, 2026 respectively.
| Parameter | SARCULATOR | D798EC00001 |
|---|---|---|
| Price | Free | Free |
| Rating | 4.3 (3 ratings) — better | — |
| Number of ratings | 3 — better | — |
| Update frequency | Every 6 months | Every 5 weeks — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 15.0 | 12.0 — better |
| Further details — not scored | ||
| Size | 29 MB | 88 MB |
| Age rating | 12+ | 12+ |
| Developer | DIGITAL FOREST SRL | ERT,INC |
In-app purchases
SARCULATOR
No in-app purchases
D798EC00001
No in-app purchases
Questions
Is SARCULATOR free?
Is D798EC00001 free?
Do SARCULATOR or D798EC00001 have ads?
Which is updated more often, SARCULATOR or D798EC00001?
Other comparisons
